Palmer Luckey Says Silicon Should Serve the People Now
Defense-tech pioneer Palmer Luckey calls for public-oversight over AI, arguing government power should guide how AI i...
Which Index Funds Are Tax Efficient 2024 Retirement
We review 2024 tax-efficient index fund options and provide practical guidance for incorporating them into a retirement strategy.
24,809 articles
Should Metals Company Stock Be a Bargain Below $7?
As demand for critical minerals grows, The Metals Company (TMC) sits at a pivotal price point. This guide explores wh...
Lawmaker Presses Kansas Over Fed Master Account Decision
A senior House Democrat is pressing the Federal Reserve Bank of Kansas City for full details on Kraken’s master accou...
TotalEnergies' Says Million Barrels: Should You Buy Oil Stocks
A single headline about 500 million barrels can spark fear or opportunity in oil investing. This article unpacks what...
Galaxy’s Novogratz BitGo Face Court Showdown in 2026
A civil suit over a $100 million claim has escalated into a courtroom confrontation between Galaxy Digital founder Mi...
Zcash Fallout After Orchard Bug Prompts Hayes Exit From Market
Arthur Hayes liquidated his entire Zcash position after a publicly disclosed Orchard Pool vulnerability. The move und...
What Home Equity Agreement Means for Homeowners in 2026
Homeowners hold trillions in tappable equity, yet tapping that wealth often requires debt. A new option, the home equ...
MoonLake Immunotherapeutics Stock Wilted: Investor Guide
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...
Global Demand Could Surge: Top Energy Stocks to Buy Now
LNG demand is primed to rise dramatically as the world leans on cleaner fuels. This guide highlights why the trend ma...
Paul: Trump’s Policy ‘As Dangerous’ Sparks Market Debate Today
Ron Paul challenges President Trump’s move to hold government stakes in private companies, arguing it threatens liber...
Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Is Crispr Therapeutics Stock Risky Right Now? A Practical Guide for Investors
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status